TrialHepatology international2018

Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.

Lai Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.